WallStreetZenWallStreetZen

NASDAQ: BLUE
Bluebird Bio Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BLUE past revenue growth

How has BLUE's revenue growth performed historically?
Company
322.6%
Industry
148.4%
Market
16.96%
BLUE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BLUE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BLUE's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BLUE earnings and revenue history

Current Revenue
$21.7M
Current Earnings
-$91.2M
Current Profit Margin
-419.6%

BLUE Return on Equity

Current Company
-34.3%
Current Industry
15.4%
Current Market
-8.4%
BLUE's Return on Equity (-34.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BLUE announces earnings.

BLUE Return on Assets

Current Company
-14.4%
Current Industry
2.2%
BLUE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BLUE Return on Capital Employed

Current Company
-21.88%
Current Industry
17.7%
BLUE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BLUE vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BLUE$21.73M-$95.08M-$91.17M-11.27%N/A
ANIX$210.00k-$10.70M-$10.74M-28.36%N/A
ELYM$0.00-$34.71M-$35.12MN/AN/A
CLSD$8.23M-$32.42M-$32.49M+207.34%N/A
VIGL$0.00-$80.88M-$82.64MN/AN/A
View Top Biotech Stocks

BLUE earnings dates

Next earnings date
May 7, 2024

Bluebird Bio Earnings & Revenue FAQ

What were BLUE's earnings last quarter?

On Invalid Date, Bluebird Bio (NASDAQ: BLUE) reported Q3 2023 earnings per share (EPS) of -$0.66, up 29.79% year over year. Total Bluebird Bio earnings for the quarter were -$71.73 million. In the same quarter last year, Bluebird Bio's earnings per share (EPS) was -$0.94.

If you're new to stock investing, here's how to buy Bluebird Bio stock.

What was BLUE's earnings growth in the past year?

As of Q2 2024, Bluebird Bio's earnings has grown year over year. Bluebird Bio's earnings in the past year totalled -$91.17 million.

What is BLUE's earnings date?

Bluebird Bio's earnings date is Invalid Date. Add BLUE to your watchlist to be reminded of BLUE's next earnings announcement.

What was BLUE's revenue last quarter?

On Invalid Date, Bluebird Bio (NASDAQ: BLUE) reported Q3 2023 revenue of $12.39 million up 17,353.52% year over year. In the same quarter last year, Bluebird Bio's revenue was $71.00 thousand.

What was BLUE's revenue growth in the past year?

As of Q2 2024, Bluebird Bio's revenue has grown 322.6% year over year. This is 174.2 percentage points higher than the US Biotechnology industry revenue growth rate of 148.4%. Bluebird Bio's revenue in the past year totalled $21.73 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.